$DNLI

01.27.20 Secondary Announcement

This content is restricted to IPO Boutique Subscribers Username or Email Password Remember me Lost your password? Become a Subscriber Disclaimer IPO Boutique aggregates information on public companies and private companies, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry[…]

Denali Therapeutics #IPO Preview $DNLI

Company: Denali Therapeutics Inc Symbol: DNLI Description: Their goal is to discover and develop therapeutics to defeat degeneration. Shares: 8.33 million Price Range: $17.00-$19.00 Trade Date: 12/8 Underwriter(s): Goldman Sachs, J.P. Morgan, Morgan Stanley Co-Manager(s): Evercore ISI Filed: 11-27-17 Link to S-1/A Prospectus Link to Retail Roadshow Business: Their total portfolio currently consists of eleven programs.[…]

Scroll to top
error: Content is protected !!